Imperative Care Archives - Medical Design Sourcing

Former Insulet exec joins Imperative Care as COO amid number of leadership moves

Imperative Care COO Chuck Alpuche [Image from Alpuche’s LinkedIn page]Imperative Care announced today that it appointed Chuck Alpuche as its new COO along with a slew of leadership changes.

The stroke care company named Peter Griffin as SVP of operations, Scott Elliott as chief legal officer and Daniel Davis as chief strategy officer, too.

Fred Khosravi, Imperative Care CEO and chair, said the moves come amid an “inflection point of operational scale and excellence.” In August, Imperative Care implemented a new organizational structure designed to accelerate growth.

The company now stands as the parent company of four businesses. These businesses all share a common goal of bringing care to those affected by stroke and other ischemic diseases.

“Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care,” Kho…

Imperative Care begins first-in-human study of neurovascular stent

Imperative Care announced today that it initiated a first-in-human clinical study for its novel neurovascular stent system.

Campbell, California-based Imperative Care designed the system to only require single antiplatelet therapy for patients undergoing stent-assisted treatment of wide-neck intracranial aneurysms.

Dr. Nobuyuki Sakai successfully treated the first three patients enrolled in the study. Sakai serves as director of neurosurgery at the Kobe City Medical Center General Hospital in Kobe City, Hyogo, Japan. All three patients underwent planned procedures for stent-assisted coiling of unruptured aneurysms.

Imperative Care reported all three patient discharges from the hospital within 48 hours on an aspirin-only antiplatelet regimen. The company reported no device- or procedure-related complications, including clot formation.

“The ability for neurovascular implants to avoid dual antiplatelet drug therapy, which carries the risk of serious …

Neurolutions, Kandu Health collab on BCI for stroke rehab

The IpsiHand system used in the collaboration with Kandu Health. [Image courtesy of Neurolutions]Neurolutions and Kandu Health today announced a strategic partnership to use brain-computer interface (BCI) in post-stroke recovery.

Santa Cruz, California-based Neurolutions designs non-invasive BCI technology for post-stroke therapy. Kandu Health, an Imperative Care subsidiary, aims to change the course of stroke recovery and post-acute care. It provides remote, multidisciplinary support after hospital discharge through a team of clinically licensed navigators and an app. Together, they aim to raise the standard of post-stroke rehabilitation.

Through this partnership, Kandu Health plans for its expert clinicians to support Neurolutions. They’ll provide clinical consultation and assessments of stroke survivors, determining who may benefit from the Neurolutions IpsiHand system.

“By combining our educational and clinical support with Neurolutions’ technolog…

How Imperative Care seeks to change the game in stroke treatment

With a new organizational structure meant to accelerate growth, Imperative Care is seeking to improve care even more for people with strokes and other ischemic diseases.

There is an urgent need for better stroke care. Strokes hit a new person every 40 seconds in the U.S. — and kill someone about every 3 minutes, according to the Centers for Disease Control and Prevention.

Imperative Care CEO Fred Khosravi sees the company achieving its goals through new device designs and bolder business models. He’s the keynote interview closing out the first day of our DeviceTalks West show, Oct. 18–19 in Santa Clara, California. (Register here.)

“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” Khosravi said in August. “We believe that the patient is the only constant in the chain of care from detection through treatment a…

Imperative Care announces new organizational structure

[Image from Imperative Care]Imperative Care announced today that it implemented a new organizational structure designed to accelerate growth.

The Campbell, California-based stroke treatment developer now stands as the parent company of four businesses. These businesses all share a common goal of bringing care to those affected by stroke and other ischemic diseases.

According to a news release, the entities under the Imperative Care umbrella include Imperative Care Stroke, Imperative Care Vascular, Kandu Health and Telos Health.

Imperative Care Stroke aims to bring life-saving interventional treatments to patients with ischemic and hemorrhagic stroke. Imperative Care Vascular — formerly Truvic Medical, acquired in 2021 — aims to advance treatments for vascular diseases. These include pulmonary embolism.

Kandu Health, a digital health company, aims to change the course of stroke recovery and post-acute care through remote support. Telo Health utilizes …

Imperative Care reports positive data for stroke treatment following expanded FDA nod

[Image from Imperative Care]Imperative Care today announced positive data from a neurovascular outcome database evaluating its Zoom stroke solution.

The announcement for the study results comes just a week after the FDA cleared an expansion to the Zoom portfolio. Imperative Care will discuss its Zoom platform and its efforts to build next-generation devices at DeviceTalks West in October. Check out the agenda and register HERE.

Campbell, California-based Imperative Care develops connected technology to treat stroke and other ischemic diseases. The Zoom stroke solution product platform aims to usher in a new era of stroke thrombectomy. It enables fast and consistent treatment, plus improved procedure outcomes. Through reperfusion, physicians can perform fast, effective clot removal in patients with ischemic stroke.

The company presented data from its Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) at the Society of NeuroInterventional Su…

Imperative Care’s Kandu Health names Kirsten Carroll CEO

Kirsten Carroll. [Image from the Kandu Health website]Imperative Care subsidiary Kandu Health appointed Kirsten Carroll as CEO amid a handful of leadership appointments.

The digital health startup aims to improve the quality of life for those affected by stroke. Kandu Health delivers tech-enabled healthcare services, providing remote support to stroke survivors and care partners after hospital discharge. It has an ongoing program that just successfully enrolled its first 50 stroke survivors.

In addition to the appointment of Carroll to the corner office, Kandu Health named another duo of executives. The company picked Stefan Heuser as CFO and Clayton Duncan as its new SVP of commercialization.

About new Kandu Health CEO Kirsten Carroll

Carroll previously served as SVP and GM for Kandu Health, leading it from inception through to formation as an independent company. She has more than 20 years of experience in stroke product development, clinical research, ma…

Study supports stroke treatment from Imperative Care

[Image from Imperative Care]Imperative Care today announced newly published data highlighting the success of its Zoom RDL radial access system.

Early data from the single-center evaluation of Zoom RDL ran in the Journal of Neurointerventional Surgery (JNIS). Imperative Care designed Zoom RDL as the first radial access platform developed specifically for treating ischemic stroke.

The Campbell, California-based company said it offers an alternative option to femoral access in treating stroke patients. It can help to enable the best possible outcome based on an individual patient’s anatomy. The system features an extended hydrophilic coating, optimized dilator and a long distal flexible segment.

Imperative Care said it designed Zoom RDL to provide .088″ intracranial access. According to the company, this demonstrated the ability to lead to faster and better reperfusion in stroke procedures.

“We are pleased to see early evidence support the u…

Former Insulet CEO Petrovic joins Imperative Care board of directors

Shacey Petrovic

Imperative Care announced that it appointed former Insulet CEO Shacey Petrovic to its board of directors, effective immediately.

Petrovic currently serves on Insulet’s board, having stepped down as CEO just over one year ago. Over three years as Insulet CEO, Petrovic helped the company grow from $2 billion in market cap to more than $20 billion. She’s also on the board of Exact Sciences and Ambu.

She now joins the board of Imperative care, which develops connected technology to treat stroke and other ischemic diseases. The Zoom stroke solution product platform aims to usher in a new era of stroke thrombectomy. It enables fast and consistent treatment, plus improved procedure outcomes. Through reperfusion, physicians can perform fast, effective clot removal in patients with ischemic stroke.

“We have been intentional in assembling the right balance of investors, executives, and industry experiences, on our board, each with their…

Study supports Imperative Care’s Zoom stroke treatment

[Image from Imperative Care]Imperative Care announced today that data backs the use of its Zoom stroke solution for treating patients with middle cerebral artery (MCA) M2 occlusions.

Campbell, California-based Imperative Care designed its Zoom Stroke solution for fast and effective clot removal. The system features the Zoom 88 large distal platform for neurovascular access, four-vessel-matched Zoom aspiration catheters, the Zoom Pump, Zoom POD and other accessories.

Data from an independent, single-center, multi-operator experience evaluating Zoom were presented by Dr. Collin Torok, neurointerventional surgeon at Midwest Radiology in Minneapolis-St. Paul, at the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) 2022 Annual Meeting in Kyoto, according to a news release.

“The Zoom stroke solution is the only system that pairs an intracranial access catheter, Zoom 88, with a range of purposefully designed vessel-matching reperfusion cat…

Studies support Imperative Care’s stroke treatment platform

The Imperative Care Zoom POD, which comprises part of the Zoom Stroke solution. [Image from Imperative Care]Imperative Care announced today that data supports the use of its Zoom Stroke solution for fast and effective clot removal.

Campbell, California-based Imperative Care designed the Zoom solution to treat those with acute ischemic stroke. It features the Zoom 88 large distal platform for neurovascular access, four-vessel-matched Zoom aspiration catheters, the Zoom Pump, Zoom POD and other accessories.

The company presented data from studies evaluating Zoom at the Society of NeuroInterventional Surgery (SNIS) 2022 19th Annual Meeting in Toronto.

“At Imperative Care, we know that clinical data are foundational to validating medical technologies and improving patient outcomes,” Daniel Davis, president and COO of Imperative Care, said in a news release. “The results from these studies are a meaningful step forward in ongoing efforts to collect real-world ev…

FDA clears Prodigy thrombectomy system from Imperative Care subsidiary Truvic

Truvic Medical, a subsidiary of Imperative Care, announced today that it won FDA 510(k) clearance for its Prodigy thrombectomy system.

Campbell, California-based Truvic — which was acquired by Imperative Care in July 2021 — designed the Prodigy thrombectomy system for the treatment of peripheral vascular thrombus.

Prodigy is used to redefine peripheral vascular thrombus management by enabling single-session thrombus removal without the use of thrombolytics, according to a news release.

“We are excited to receive FDA clearance for our first thrombectomy system. We look forward to working with experts in the field to translate Prodigy’s novel design elements and features into superb clinical outcomes,” Truvic CEO Mike Buck said in the release. “This represents our first regulatory milestone as part of our strategy to advance multiple programs designed to meet patients’ needs and bring more innovative technologies to the market, faster.”